Diabetes technology & therapeutics
Clinical Impact of Continuous Glucose Monitoring in Noninsulin Treated Type 2 Diabetes: A Review.
Grazia Aleppo, Anders L Carlson, Janet B McGill, Hamza Alshannaq, Rodolfo Galindo, Davida Kruger, Carol J Levy, Jessica Y Matuoka, Sabrina Ilham, Guillermo Umpierrez, Gregory J Norman
Published: 202610.1177/15209156251414980
Abstract
Continuous glucose monitoring (CGM) technology is becoming increasingly available to people with diabetes using insulin therapy; however, availability for people with type 2 diabetes (T2D) not on insulin remains limited. For people with T2D, there is…
Preview only. Read the full abstract at the source